Related by context. All words. (Click for frequent words.) 70 antiretroviral naïve 69 seroconverted 68 coinfection 68 seronegative 68 HBeAg negative 67 HIV coinfected 67 CC genotype 67 HBeAg positive 66 monoinfected 66 HIV uninfected 66 HBeAg negative patients 66 BCG vaccinated 65 coinfected patients 65 NNRTI resistance 65 genital ulcers 65 virologic failure 65 dapagliflozin plus 65 HCV infected 65 HCV genotype 65 immunocompetent 65 achieved ACR# 65 hepatitis C genotype 65 discontinued Viread 65 chronic HCV infection 65 HIV HCV coinfected 65 nevirapine Viramune 64 K ras mutations 64 TEAEs 64 rectal gonorrhea 64 chronic HBV 64 aged ≥ 64 receiving antiretroviral therapy 64 log# reduction 64 stage IIIb IV 64 ribavirin therapy 64 TT genotype 64 tipranavir ritonavir 64 experienced virologic failure 64 seropositivity 64 indinavir 64 e antigen HBeAg 64 recurrent genital herpes 64 antiretroviral naive 64 pT3 63 antibody titer 63 umol L 63 adverse reactions incidence 63 hormone receptor negative 63 BRCA2 mutations 63 advanced adenomas 63 pulmonary Pseudomonas aeruginosa 63 patients coinfected 63 immunosuppressed 63 HNSCC 63 Asymptomatic 63 heterosexually acquired 63 KRAS mutations occur 63 immunodeficient 63 nonmetastatic 63 chronic HCV genotype 63 basal cell nevus syndrome 63 advanced adenoma 63 HER2 positive cancers 63 HBeAg seroconversion 63 HBeAg 62 UGT#A# * 62 MTHFR 62 seropositive 62 severe neutropenia 62 BARACLUDE ® 62 KRAS mutations 62 Pneumocystis carinii pneumonia 62 shorter telomere length 62 poor metabolizers 62 lopinavir r arm 62 chronic HCV 62 NRTI resistance 62 ritonavir boosted 62 log# copies mL 62 genotypic resistance 62 elevated ALT 62 System IPSS 62 TDF FTC 62 Baseline characteristics 62 decompensated liver disease 62 relapsed MM 62 asymptomatic carriers 62 del 5q MDS 62 undetectable viral load 62 abacavir lamivudine 62 nonobese 62 S. aureus isolates 62 HCV genotypes 62 virus HBV 62 mCRPC 62 osteosarcomas 62 HIV seropositive 62 infliximab monotherapy 62 sustained virologic response 62 ALT flares 62 urethritis 62 stage IIIB 62 3TC lamivudine Epivir 62 recurrent glioblastoma multiforme 62 nondiabetic patients 62 pg ml 62 seropositive patients 62 monoinfected patients 62 NNRTI resistant virus 62 R5 tropic 62 undetectable HBV DNA 62 Chronic Hepatitis C 62 Relapsed Refractory 62 REYATAZ r arm 62 pyrexia mucositis sepsis febrile 62 C. trachomatis 61 ug dose 61 squamous histology 61 nondiabetic 61 oropharyngeal candidiasis OPC 61 polyp recurrence 61 HBV infections 61 anthracycline containing 61 CCR5 delta# 61 Plasmodium ovale 61 HCV genotype 1 61 HER2 expression 61 MetS 61 generalized edema 61 IgA deficiency 61 genotype 1b 61 elevated triglyceride levels 61 elevated transaminases 61 chronic hepatitis cirrhosis 61 Ribavirin causes 61 mIU ml 61 recurrent VTE 61 #.#ng/ml 61 relapsed ALL 61 leukemia ALL 61 fluvastatin 61 % CI #.#-#.# [003] 61 % CI #.#-#.# [007] 61 lupus anticoagulant 61 minimally symptomatic 61 8mg/kg 61 rs# [001] 61 NRTI backbone 61 HPV genotypes 61 MYH9 gene 61 flutamide 61 BRAF V#E 61 hepatocellular carcinomas 61 nonnucleoside reverse transcriptase inhibitors 61 monozygotic twin 61 -#.# log# copies mL 61 histologically confirmed 61 adalimumab Humira 61 invasive fungal infection 61 T2DM 61 certolizumab 61 mcg albinterferon alfa 2b 61 HIV RNA 61 transferrin saturation 61 Ishak fibrosis score 61 underwent surgical resection 61 histologies 61 initiating antiretroviral therapy 61 external genital lesions 61 EGFR mutation positive 61 virus HCV infection 61 neutrophil counts 61 HER2 amplification 61 μmol L 61 % CI #.#-#.# [006] 61 HER2 negative 61 micafungin 61 treatment naïve genotype 61 testicular germ cell 61 HLA DR2 61 genotype 1a 61 superinfection 61 ertapenem 61 PROSTVAC VF 61 biochemical relapse 61 achieve sustained virological 61 heavily pretreated 61 neutropenia dehydration dyspnea 61 GSTM1 61 Flu Cy 61 virologically 60 rituximab refractory 60 leukemia CLL 60 achieved sustained virological 60 virological failure 60 anemia neutropenia 60 papillary renal cell carcinoma 60 small lymphocytic lymphoma 60 HBeAg positive patients 60 ano genital warts 60 ErbB2 positive 60 CCyR 60 CTAP# Capsules 60 undergone radical prostatectomy 60 HCV infection 60 median CD4 60 alanine aminotransferase ALT 60 MGUS 60 orchitis 60 AZT zidovudine Retrovir 60 HCV infections 60 efavirenz Sustiva 60 highest tertile 60 Myelodysplastic Syndrome MDS 60 aplastic anemia AA 60 EGFR mutations 60 ABCB1 60 complete cytogenetic response 60 ALT normalization 60 P aeruginosa 60 pCR 60 Hepsera adefovir dipivoxil 60 copies ml 60 Leukemias 60 seroprotection 60 Opportunistic infections 60 BRCA1 mutation carriers 60 virologic response 60 achieved CCyR 60 sustained virological response 60 T1DM 60 leukemia AML 60 receiving VICTRELIS 60 Hodgkin lymphoma HL 60 combination antiretroviral therapy 60 lipid lowering medications 60 peginterferon alfa 2a Pegasys 60 HBsAg 60 mmol l 60 NNRTIs 60 mutated K ras 60 prostate cancer CaP 60 locoregional recurrence 60 mcg BID 60 clade B 60 receiving XGEVA 60 LTBI 60 chronically infected 60 Circumcised men 60 invasive ductal 60 HAART regimens 60 subclinical hyperthyroidism 60 autoimmune thyroid 60 euthyroid 60 KRAS oncogene 60 receiving VELCADE 60 neurodevelopmental impairment 60 anthracycline taxane 60 progesterone receptor negative 60 baseline HbA1c 60 #q#.# deletion syndrome 60 K#N 60 oral antidiabetic agents 60 candidemia 60 T1c 60 confidence interval #.#-#.# 60 oxycodone CR 60 Celiac disease affects 60 completely resected 60 anagrelide 60 rs# [004] 60 q#h 60 nucleoside naive 60 unprotected vaginal 60 receiving immunosuppressive therapy 60 histologic subtype 60 neurologic complications 60 apolipoprotein E4 60 onset diabetes mellitus 60 castrate resistant 60 anemia hemoglobin 60 bacteraemia 60 SSc 60 hepatitis B infection 59 ALT elevation 59 alanine aminotransferase 59 HBV infection 59 Relapsed Refractory Multiple Myeloma 59 hyper IgE syndrome 59 virological response 59 HCV antibody 59 Thal Dex 59 causes genital herpes 59 narcolepsy cataplexy 59 hepatorenal syndrome 59 prior chemotherapy regimens 59 chronic HBV infection 59 reverse transcriptase inhibitors 59 fluoroquinolone resistant 59 chlamydial infections 59 ALI ARDS 59 subtyped 59 CIN3 59 symptomatic BPH 59 glycated hemoglobin levels 59 mg q#h 59 HBeAg + 59 lamivudine resistant 59 heterozygotes 59 adriamycin 59 Myelodysplastic syndromes 59 clodronate 59 caspofungin 59 μg doses 59 abnormal cytology 59 seroconversion 59 diabetes mellitus DM 59 hypophosphatemia 59 resected pancreatic cancer 59 macroalbuminuria 59 nondepressed 59 CrCl 59 eosinophilic asthma 59 CRp 59 mL/min/#.# m 2 59 castrate resistant prostate cancer 59 invasive lobular 59 antiandrogens 59 invasive carcinomas 59 endometrial ovarian 59 deep venous thromboses 59 chlamydial infection 59 HLA DR4 59 hemorrhagic cystitis 59 virologically suppressed 59 methotrexate monotherapy 59 erlotinib Tarceva ® 59 vWD 59 underwent resection 59 cART 59 hydroxyvitamin D levels 59 CCR5 tropic HIV 59 liver metastasis 59 HGPIN 59 relapsed SCLC 59 HPV subtypes 59 abacavir Ziagen 59 MELD scores 59 CCR5 tropic 59 CP CPPS 59 potent antiretroviral therapy 59 lumbar spine BMD 59 recurrent wheezing 59 elevated serum creatinine 59 viremic 59 atypical hyperplasia 59 protein excretion 59 autoantibody positive 59 prescribed statins 59 virologic responses 59 pyelonephritis 59 CIMZIA TM certolizumab pegol 59 naïve HCV 59 Hurthle cell 59 MLH1 59 myelodysplastic myeloproliferative diseases 59 CR nPR 59 chorioamnionitis 59 tolterodine ER 59 #ng/ml 59 tuberculin skin testing 59 Doxil ® 59 Peg IFN 59 immuno suppressed 59 HER2 positive tumors 59 neoplasias 59 osteopenic 59 chlorambucil 59 % CI #.#-#.# [008] 59 metastatic renal cell 59 leukopenia 59 lymphocytosis 59 grade cervical intraepithelial 59 homozygous familial hypercholesterolemia 59 alfa 2a 59 gestational hypertension 59 lenalidomide Revlimid R 59 heterozygous 59 deletion 5q 59 HepC 59 haematologic 59 systolic dysfunction 59 idiopathic PAH 59 tamoxifen Nolvadex ® 59 AADs 59 tipranavir r 59 immunocompromised 59 invasive aspergillosis 59 transaminase elevations 59 decompensated cirrhosis 59 receiving prophylactic anticoagulation 59 amoxicillin clavulanate 59 HIV seronegative 59 FluCAM arm 59 NMIBC 59 asymptomatic PAD 59 KRAS mutant tumors 59 protease inhibitor PI 59 BRCA1 mutations 59 adverse reactions occurring 59 receiving INTRON 59 genital ulcer 59 cirrhosis liver failure 59 lipohypertrophy 59 tenofovir emtricitabine 59 tanned indoors 59 evaluating tivozanib 59 genital ulcer disease 58 epithelial tumors 58 β blockers 58 skeletal metastases 58 latent tuberculosis infection 58 methylenetetrahydrofolate reductase 58 aminotransferase levels 58 recurrent venous thromboembolism 58 achieve sustained virologic 58 thyrotropin levels 58 adiponectin concentrations 58 lowest tertile 58 prostate carcinoma 58 antiandrogen 58 bone marrow reticulin deposition 58 viraemia 58 cEVR 58 undetectable virus HCV 58 polytherapy 58 fluconazole resistant 58 pegylated interferon alpha 58 sUA 58 HBeAg negative chronic hepatitis 58 CD8 responses 58 CMV infection 58 normotensive 58 oral antidiabetic medication 58 IELT 58 HIV seroconversion 58 ceftazidime 58 dasatinib Sprycel 58 lactate dehydrogenase LDH 58 elevated LDH 58 hepatitis C HCV 58 prolonged QT interval 58 HLA DRB1 * 58 RG# nucleoside analog 58 rheumatoid arthritis inflammatory bowel 58 abnormal Pap test 58 normal karyotype 58 visceral metastases 58 born preterm 58 Genotypes 58 x ULN 58 genital HSV 58 Viread Emtriva 58 APOE e4 58 laboratory abnormalities 58 NS5b 58 advanced neoplasia 58 stage IIIB IV 58 elevated LDL cholesterol 58 estrogen receptor negative 58 baseline CD4 58 hypogonadal 58 metastatic malignant 58 LymphoStat B belimumab 58 adenomatous polyps 58 MYCN amplification 58 Median survival 58 anal cancers 58 lopinavir r 58 PSADT 58 PSA nadir 58 PDGFRA 58 FOLFOX6 58 AML MDS 58 treatment naive genotype 58 FLT3 mutations 58 gemcitabine carboplatin 58 hyperphenylalaninemia HPA due 58 HbA 1c levels 58 hemodynamically significant 58 lopinavir 58 non splenectomized 58 baseline serum creatinine 58 APTIVUS r 58 metastatic RCC 58 fasting triglyceride levels 58 baseline PASI 58 zidovudine lamivudine 58 nonmelanoma skin cancer 58 CMV seropositive 58 FluCAM 58 resistant hormone refractory 58 plus methotrexate 58 interferon alfa 2a 58 haloperidol Haldol 58 pT2 58 STELARA ® 58 Stage IIIb 58 PREZISTA r 58 PegIFN RBV 58 pentoxifylline 58 KRAS wild 58 heFH 58 nulliparous women 58 ribavirin RBV 58 lung ovary 58 dysplastic lesions caused 58 muscular dystrophy cystic fibrosis 58 hsCRP levels 58 voriconazole 58 baseline neutrophil counts 58 Renal impairment 58 chronic GVHD 58 thromboembolic complications 58 PREZISTA r arm 58 MMSE scores 58 ductal breast cancer 58 ALT elevations 58 nonischemic 58 CIN2 + 58 medically inoperable 58 gemifloxacin 58 co trimoxazole 58 rilpivirine 58 juvenile idiopathic arthritis JIA 58 highly emetogenic 58 hypercholesterolemic patients 58 viral loads 58 genotyped 58 SGPT 58 initiating HAART 58 evaluable subjects 58 lipid elevations 58 undergo prostate biopsy 58 noncarriers 58 lactate dehydrogenase 58 dalteparin 58 nonadherent 58 superficial vein thrombosis 58 IU mL 58 herpes zoster shingles 58 darunavir 58 psoriatic arthritis PsA 58 Amgen Neulasta ® 58 HLA DQ2 58 pancreatic adenocarcinoma 58 pegylated alpha interferon 58 adjunctive ABILIFY 58 adefovir 58 recurrent metastatic 58 morphometric vertebral fractures 58 nucleoside analogues 58 unresectable HCC 58 gastric carcinogenesis 58 fallopian tube carcinoma 58 CagA 58 SJIA 58 Complication rates 58 undetectable hepatitis C 58 unfavorable genotypes 58 oral FTY# 58 rizatriptan 58 overt hypothyroidism 58 highest quintile 58 telomere lengths 58 Acute Exacerbations 58 hematologic abnormalities 58 HBV DNA 58 trimethoprim sulfamethoxazole 58 Ph + acute lymphoblastic 58 ADPKD 58 BRAF V# mutation 58 Papillary 58 ddI 58 recurrent UTI 58 BRCA2 carriers 58 chemoresistant 58 gonococcal infections 58 cSSSIs 58 TroVax ® 58 nmol liter 58 pyridostigmine 58 enterococcal 58 liver histology 58 gonococcal 58 valacyclovir 58 inherited mutations 58 severe renal impairment 58 imatinib Gleevec ® 58 CYT# potent vascular disrupting 58 DAS# scores 58 sotalol 58 serum concentrations 58 pegylated interferon alfa 2a 58 advanced hepatocellular carcinoma 58 atopic 58 endometrial carcinoma 58 HPV-#/# 58 Naive Patients 58 trastuzumab Herceptin ® 58 GG genotype 58 Nonalcoholic fatty liver 58 apolipoprotein B 58 cirrhotic 58 comparator arm 58 intravenous bisphosphonates 58 APOE ε4 58 PsA 57 prevalent sexually transmitted 57 N. gonorrhoeae 57 #mg BID [003] 57 CsA 57 biologic DMARD 57 lamivudine refractory patients 57 neonatal lupus 57 Pharmacokinetics PK 57 squamous cell lung cancer 57 serum ALT 57 Trichomonas vaginalis 57 pneumocystis carinii pneumonia 57 baseline A1C 57 HPV vaccine protects 57 smoldering myeloma 57 adjuvant tamoxifen 57 Chronic hepatitis C 57 severe periodontitis 57 receiving golimumab 57 anal HPV 57 colorectal neoplasia 57 chronic periodontitis 57 prednisone prednisolone 57 cryptococcal meningitis 57 endometrial hyperplasia 57 lamivudine 57 latent TB infection 57 paricalcitol 57 Protease Inhibitors 57 essential thrombocythemia ET 57 mcg kg REBETOL 57 TMP SMX 57 TMC# r 57 achieved statistical significance 57 receiving ISENTRESS 57 blastic phase 57 novel VDA molecule 57 acute leukemias 57 tryptase 57 CD4 counts 57 HBsAg positive 57 lymphoid malignancies 57 mg TID 57 mRCC 57 bezafibrate 57 basal cell carcinoma BCC 57 distant metastasis 57 endometrial thickness 57 colorectal carcinomas 57 Chlamydia pneumoniae 57 nadroparin 57 creatinine clearance 57 proband 57 gallstone disease 57 operable breast cancer 57 hepatocellular carcinoma HCC 57 de novo AML 57 Chronic ITP 57 renal cell carcinomas 57 abdominally obese 57 metastatic hormone refractory 57 infliximab 57 rheumatoid factor 57 atrophic gastritis 57 atopic disorders 57 recurrent NSCLC 57 ovarian endometrial 57 neuroendocrine cancers 57 microbiological eradication 57 GH deficiency 57 methicillin resistant MRSA 57 HIV coinfection 57 tumors GIST 57 DQB1 * 57 recurrent myocardial infarction 57 GBA mutations 57 #q# deletion syndrome 57 #mg BID [001] 57 typical antipsychotics 57 Pegylated Interferon 57 histologically active 57 onset idiopathic hypogonadism 57 EpCAM expression 57 c KIT 57 #.#mg/dL 57 diabetic kidney 57 underwent liver transplantation 57 lamivudine Epivir 57 untreated celiac disease 57 oral vancomycin 57 varicella zoster virus VZV 57 alpha interferons 57 amprenavir 57 specific antigen PSA 57 #q# deletion 57 trastuzumab Herceptin R 57 biochemical recurrence 57 enteroviral 57 Hashimoto thyroiditis 57 pegIFN 57 MRSA isolates 57 RSV infections 57 sero positive 57 HLA A2 57 AVODART 57 BRCA2 gene mutation 57 asymptomatic 57 fluticasone salmeterol 57 null responder 57 microalbumin test 57 intraventricular hemorrhage 57 latently infected 57 unresectable stage 57 baseline LDH 57 hypermethylated 57 follicular lymphoma FL 57 receptor blocker 57 nonexposed 57 neutropenic patients 57 dacarbazine DTIC 57 progression TTP 57 beta interferons 57 undetectable viral loads 57 pharmacokinetic interactions 57 mitoxantrone chemotherapy 57 dasatinib Sprycel ® 57 congenital deficiency 57 malignant neoplasm 57 atazanavir 57 receiving highly emetogenic 57 HAART regimen 57 Escherichia coli Klebsiella pneumoniae 57 promoter methylation 57 ritonavir boosted atazanavir 57 endoscopic remission 57 moderate renal impairment 57 thrombocytopenic 57 Amgen Neulasta R 57 HER2 overexpression 57 ethambutol 57 familial ALS 57 BMPR2 57 emtricitabine tenofovir 57 -#.# log# 57 Mg Uk 57 S aureus 57 peginterferon alfa 2a 57 allele frequencies 57 posaconazole 57 nonmelanoma 57 imatinib Gleevec 57 Index CDAI 57 VELCADE melphalan 57 prostate adenocarcinoma 57 Chlamydia infection 57 intracranial hemorrhage ICH 57 genital lesions 57 plus OBT 57 salmeterol HFA MDI 57 hypersensitivity reactions eg anaphylaxis 57 RLAI 57 colorectal adenoma 57 imatinib therapy 57 interferon ribavirin 57 PCa 57 HAART 57 autoantibody levels 57 hematologic toxicity 57 nonfasting triglyceride levels 57 monoclonal gammopathy 57 copies mL 57 ASCUS 57 methicillin sensitive 57 elevated depressive symptoms 57 refractory chronic lymphocytic 57 dermatologic reactions 57 smoldering multiple myeloma 57 docetaxel chemotherapy 57 Viread Emtriva Sustiva 57 DAS# CRP 57 congenital CMV 57 asymptomatic metastatic 57 poorer prognosis 57 Hepatitis B Virus 57 LV dysfunction 57 ritonavir boosted protease inhibitor 57 CI #.#-#.# [001] 57 TTR amyloidosis 57 PAOD 57 polymicrobial 57 ECOG PS 57 q8h 57 #mg ATC 57 rapid virologic response 57 latent celiac disease 57 intestinal metaplasia 57 PASI scores 57 bexarotene 57 Epivir HBV 57 mg ustekinumab 57 hematological parameters 57 adverse cytogenetics 57 CHD CVD 57 minimally symptomatic metastatic castrate 57 ACR# responses 57 administering XIFAXAN 57 severe rotavirus gastroenteritis 57 cervical intraepithelial neoplasia 57 potentially hepatotoxic 57 systemically administered 57 EBV infection 57 humanized interleukin 6 57 carotid plaques 57 splenectomized patients 57 liver transplant recipients 57 cells uL 57 nonmelanoma skin cancers 57 TP# mutations 57 pyrazinamide 57 myeloproliferative neoplasms 57 ng dL 57 OIs 57 metastatic malignant melanoma 57 lymphocyte count 57 paclitaxel cisplatin 57 non pledgers 57 AZT 3TC 57 PCA3 scores 57 coinfections 57 plasma folate 57 CVD mortality 57 myocardial infarctions 57 nonvertebral fractures 57 selective modulator 57 MMSE score 57 leukaemias 57 leukemia multiple myeloma 57 syngeneic 57 nonalcoholic steatohepatitis NASH 57 nodal metastasis 57 LHRH receptor positive 57 MADRS score 56 preterm deliveries 56 Infected Patients 56 histologically proven 56 pre eclamptic 56 lopinavir ritonavir plus 56 alemtuzumab treated 56 Trichophyton rubrum 56 Peginterferon Alfa 2a 56 cytopathic 56 IL#B 56 androgen independent 56 IGFBP 56 androgen deprivation 56 abnormal lipid 56 SLNB 56 acute lymphoid leukemia 56 nonresponders 56 virus XMRV 56 non metastatic osteosarcoma 56 nonischemic cardiomyopathy 56 null responders 56 transcriptase inhibitors 56 benazepril 56 gefitinib Iressa 56 GABHS 56 Adjuvant chemotherapy 56 PLX STROKE targeting 56 amisulpride 56 administered concomitantly 56 Diffuse Large B 56 HCV Genotype 56 Hepatitis B virus 56 reduce serum phosphate 56 asthma rhinitis 56 multidrug resistant 56 Pegasys ® 56 genotype 56 drank pomegranate juice 56 pneumoniae 56 #mg dose [002] 56 COPD exacerbation 56 homozygotes 56 perinatally infected 56 TRAIL R1 56 response CCyR 56 Scale EDSS 56 PEG Interferon alfa 56 radezolid 56 beta carotene supplementation 56 4mg/kg 56 VTEs 56 metastatic gastric 56 C#Y 56 gastric carcinoma 56 atopic asthma 56 serum creatinine levels 56 microbiologically evaluable 56 cytogenetic responses 56 HbF 56 lobular cancer 56 immunosuppressed patients 56 Cutaneous T 56 substantially excreted 56 genital herpes infections 56 NNRTI 56 lichen planus 56 macroglobulinemia 56 de ath 56 SIMPONI ® 56 M. genitalium 56 FUSILEV enhances 56 hepatitis B HBV 56 HIV serostatus 56 Lymphocytic 56 Squamous 56 receptor inhibitor 56 anovulatory 56 undetectable viral 56 CYP#C# * 56 boosted protease inhibitor 56 annualized relapse 56 Philadelphia Chromosome Positive 56 Epstein Barr virus EBV 56 TYMS 56 receiving TNF blockers 56 acid phosphatase PAP 56 Vidaza ® 56 definite stent thrombosis 56 nutlin 3a 56 TNF blocker therapy 56 Uterine cancer 56 LEXIVA r 56 undergoing bariatric surgery 56 nonseminoma 56 fosamprenavir 56 Hypersensitivity reactions 56 refractory NSCLC 56 variant allele 56 serologic testing 56 mycophenolate mofetil 56 #mg q8h 56 protease inhibitors PIs 56 Neisseria gonorrhoeae 56 invasive pneumococcal infections 56 postexposure prophylaxis 56 herpesviruses 56 Apolipoprotein E4 56 Tay Sachs thalassemia 56 unprotected receptive anal 56 viremia 56 dopaminergic therapy 56 International Prognostic Scoring 56 efavirenz EFV 56 preeclamptic 56 aminotransferases 56 elevated triglycerides 56 seroprevalence 56 ABC/3TC 56 parasitaemia 56 serum PSA 56 nicardipine 56 stavudine d4T 56 cryptogenic 56 ® lenalidomide 56 unknown etiology 56 metformin monotherapy 56 hepatic fibrosis 56 Febrile neutropenia 56 REMICADE monotherapy 56 antibody titers 56 oncogenic HPV 56 invasive candidiasis 56 colon carcinoma 56 daunorubicin 56 partial remissions 56 pneumococcal infection 56 Haptoglobin 56 non progressors 56 Enterococcus faecium